Could a lung fibrosis drug stop nosebleeds in HHT?
Symptom relief
Recruiting now
This study tests whether nintedanib, a drug already used for lung scarring, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). About 48 adults with moderate to severe nosebleeds will take either nintedanib or a placebo twice daily for 16 weeks. The …
Phase: PHASE2 • Sponsor: Dr. Romain Lazor • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC